Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro.
EBioMedicine. 2021 Dec;74:103712. doi: 10.1016/j.ebiom.2021.103712. Epub 2021 Nov 25.
EBioMedicine. 2021.
PMID: 34839261
Free PMC article.